Global Gynecology Surgical Devices Market 2017-2021
About Gynecology Surgical Devices
Gynecology surgical devices are in high demand for conditions including excessive uterine bleeding, ovarian cancer, cervical cancer, and others. Some conditions are treated without any complications, whereas, some of the procedures involve complications. Several advanced devices and technologies are used to perform complex gynecological procedures. Different portable and disposable devices are available in gynecology and fertility centers.
Technavio’s analysts forecast the global gynecology surgical devices market to grow at a CAGR of 3.17% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global gynecology surgical devices market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Gynecology Surgical Devices Market 2017-2021
Technavio recognizes the following companies as the key players in the global gynecology surgical devices market: CooperSurgical, Hologic, Boston Scientific, Intuitive Surgical, Karl Storz, and Thermo Fisher Scientific.
Other Prominent Vendors in the market are: ACTEON Group, BD, Carl Zeiss Meditec, CONMED, Endotherapeutics, Ethicon, MedGyn Products, Medtronic, Minerva Surgical, NovaTract Surgical, Olympus Medical, Richard Wolf, Thermedx, Titan Medical, TransEnterix, Wallach Surgical, and WISAP Medical Technology.
Commenting on the report, an analyst from Technavio’s team said: “One trend in market is increasing adoption of robotic navigation technologies for laparoscopy. Technological innovations in ablation procedures have led to high accuracy with advanced needle placement technology to provide better support for both patients and surgeons. Robotic technology helps enhance surgeon's skills and reduces variability. It also helps in reduction of incision and improvement of recovery time.”
According to the report, one driver in market is growing hospital investments in gynecology surgical instruments. Endoscopy is the most common surgical technique used for the treatment of gynecological disorders. Different endoscopy devices are used to enhance the success rate of these procedures. The growth in older population along with the rising incidence of cervical cancer, ovarian cancer, and other gynecological disorders contribute to the high consumption of gynecological surgical devices such as endoscopy ablation systems and endometrial ablation systems. The rising incidence of gynecological disorders and higher success rate of these devices are driving the hospital investment in endoscopy instruments. For instance, in November 2016, Hologic launched the advanced NovaSure global endometrial ablation system for enhancing the treatment of abnormal uterine bleeding. The product was launched in Europe, Canada, and Australia with CE mark approval. Hospital investments in these devices in APAC and EMEA increase patient comfort and operational success rate.
Further, the report states that one challenges in market is high cost of treatment. Healthcare systems and hospitals are under constant pressure to deliver quality care at low cost. However, this has become difficult due to the implementation of advanced MI procedures that involve the use of sophisticated devices. Hospitals and healthcare institutions need to consider various procurement processes and budget constraints before purchasing laparoscopic and endoscopic devices for gynecological surgeries. Healthcare providers also need to maintain their devices in efficient working condition, which increases the overall rate of treatment. Laparoscopic surgeries such as robot-assisted procedures cost 60% more than conventional surgeries. The average additional cost per person per robotic treatment is about $1,600, which will exceed $3,000 if the cost of the robotic device is considered. The initial investment for the installation of robotic devices is $1-$2 million, and associated annual maintenance cost is $200,000-$250,000. Disposables such as shears, needles, drivers, graspers, and forceps used during the surgeries also add up to the total expenditure. Apart from robot-assisted surgeries, the cost of devices for conducting MI laparoscopic procedures and prostatectomy is also high.
CooperSurgical, Hologic, Boston Scientific, Intuitive Surgical, Karl Storz, Thermo Fisher Scientific, ACTEON Group, BD, Carl Zeiss Meditec, CONMED, Endotherapeutics, Ethicon, MedGyn Products, Medtronic, Minerva Surgical, NovaTract Surgical, Olympus Medical, Richard Wolf, Thermedx, Titan Medical, TransEnterix, Wallach Surgical, and WISAP Medical Technology.